Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)

Clinical trial NCT04699071 · UNKNOWN

Trial details

NCT number: NCT04699071
Sponsor: National University Hospital, Singapore
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinomas Recurrent Gynecological

Start date: 2021-02-18
Primary completion: 2024-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.